Discovery of 2,4-dimethoxypyridines as novel autophagy inhibitors

Lucas Robke, Tiago Rodrigues, Peter Schröder, Daniel J. Foley, Gonçalo J.L. Bernardes, Luca Laraia*, Herbert Waldmann

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

145 Downloads (Pure)


Autophagy is a catabolic process, which mediates degradation of cellular components and has important roles in health and disease. Therefore, small molecule modulators of autophagy are in great demand. Herein, we describe a phenotypic high-content screen for autophagy inhibitors, which led to the discovery of a dimethoxypyridine-based class of autophagy inhibitors, which derive from previously reported, natural product-inspired MAP4K4 inhibitors. Comprehensive structure-activity relationship studies led to a potent compound, and biological validation experiments indicated that the mode of action was upstream or independent of mTOR
Original languageEnglish
Pages (from-to)4531-4537
Publication statusPublished - 2018


  • Autophagy
  • Phenotypic screening
  • High-throughput screening
  • Natural products
  • Medicinal chemistry


Dive into the research topics of 'Discovery of 2,4-dimethoxypyridines as novel autophagy inhibitors'. Together they form a unique fingerprint.

Cite this